openPR Logo
Press release

Cancer Immunotherapy Drug Discovery Outsourcing Market worth $4.41 billion by 2030, growing at a CAGR of 15.52% - Exclusive Report by 360iResearch

10-21-2023 10:35 AM CET | Health & Medicine

Press release from: 360iResearch

Cancer Immunotherapy Drug Discovery Outsourcing Market | 360iResearch

Cancer Immunotherapy Drug Discovery Outsourcing Market | 360iResearch

The "Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/cancer-immunotherapy-drug-discovery-outsourcing?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Market Segmentation & Coverage:

This research report categorizes the Cancer Immunotherapy Drug Discovery Outsourcing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Cancer Type, market is studied across Breast, Colorectal, Head and Neck, Lung, Melanoma, Ovarian, Pancreatic, and Prostate. The Pancreatic is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Immunomodulators, Monoclonal Antibodies, and Oncolytic Viral Therapies & Cancer Vaccines. The Immunomodulators is projected to witness significant market share during forecast period.

Based on Service Type, market is studied across Cell-based Assays, Lead Screening & Characterization, and Target Identification & Validation. The Lead Screening & Characterization is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Cancer Immunotherapy Drug Discovery Outsourcing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Cancer Immunotherapy Drug Discovery Outsourcing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Cancer Immunotherapy Drug Discovery Outsourcing Market, highlighting leading vendors and their innovative profiles. These include BPS Bioscience, Inc., Celentyx Ltd., Charles River Laboratories International, Inc., Covance, Inc., Crown Bioscience, Inc., Curia Inc., Dalton Pharma Services, DiscoverX Corporation, Eurofins Scientific, Evotec SE, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Ltd., Horizon Discovery Group PLC, ImmunXperts SA, Jubilant Life Sciences Limited, Labcorp, Oncodesign Precision Medicine Opm SA, Personalis, Inc., Promega Corporation, STC Biologics Inc., TCG Lifesciences Pvt. Limited, and WuXi AppTec Co., Ltd..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer Type
7. Cancer Immunotherapy Drug Discovery Outsourcing Market, by Drug Type
8. Cancer Immunotherapy Drug Discovery Outsourcing Market, by Service Type
9. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market
10. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
11. Europe, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Cancer Immunotherapy Drug Discovery Outsourcing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Cancer Immunotherapy Drug Discovery Outsourcing Market?
3. What is the competitive strategic window for opportunities in the Cancer Immunotherapy Drug Discovery Outsourcing Market?
4. What are the technology trends and regulatory frameworks in the Cancer Immunotherapy Drug Discovery Outsourcing Market?
5. What is the market share of the leading vendors in the Cancer Immunotherapy Drug Discovery Outsourcing Market?
6. What modes and strategic moves are considered suitable for entering the Cancer Immunotherapy Drug Discovery Outsourcing Market?

Read More @ https://www.360iresearch.com/library/intelligence/cancer-immunotherapy-drug-discovery-outsourcing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Immunotherapy Drug Discovery Outsourcing Market worth $4.41 billion by 2030, growing at a CAGR of 15.52% - Exclusive Report by 360iResearch here

News-ID: 3259121 • Views:

More Releases from 360iResearch

Surfactants Market worth $90.55 billion by 2030, growing at a CAGR of 6.83% - Exclusive Report by 360iResearch
Surfactants Market worth $90.55 billion by 2030, growing at a CAGR of 6.83% - Ex …
The "Surfactants Market by Product (Amphoteric Surfactants, Anionic Surfactants, Cationic Surfactants), Substrate (Bio-Based surfactant, Synthetic Surfactants), Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/surfactants?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Key Drivers Shaping the Surfactant Market: Embracing Innovation and Sustainability" Surfactants, crucial for enhancing cleaning efficiency and foam generation, are widely used in home care and personal hygiene products like detergents, soaps, and shampoos. The global emphasis on
Electric Cordless Lawn & Garden Tools Market worth $17.53 billion by 2030, growing at a CAGR of 8.53% - Exclusive Report by 360iResearch
Electric Cordless Lawn & Garden Tools Market worth $17.53 billion by 2030, growi …
The "Electric Cordless Lawn & Garden Tools Market by Tools (Chainsaws, Leaf blower, Trimmers & Edger), Battery Type (Lead-acid, Lithium-ion), End-use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/electric-cordless-lawn-garden-tools?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Surge in Demand for Eco-Friendly and Efficient Electric Cordless Lawn & Garden Tools Driven by Urbanization and Environmental Policies" The rising trend of urban gardening, alongside stricter environmental regulations aimed at reducing emissions and
Digital Talent Acquisition Market worth $56.57 billion by 2030, growing at a CAGR of 9.47% - Exclusive Report by 360iResearch
Digital Talent Acquisition Market worth $56.57 billion by 2030, growing at a CAG …
The "Digital Talent Acquisition Market by Training (External, Internal), Certification (AI Developers, Cloud Computing & Security, Data Management), Industry - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/digital-talent-acquisition?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Expanding Digital Workforce and Advanced Hiring Technologies Propel Growth in Digital Talent Acquisition Market" As companies increasingly incorporate technology into everyday business practices, the need for proficient digital workers is surging, prompting advancements in digital talent
Overhead Catenary System Market worth $58.54 billion by 2030, growing at a CAGR of 10.79% - Exclusive Report by 360iResearch
Overhead Catenary System Market worth $58.54 billion by 2030, growing at a CAGR …
The "Overhead Catenary System Market by Type (Compound Catenary Wire, Simple Catenary Wire, Stitched Catenary Wire), Component (Cantilever, Catenary Wire, Contact Wire), Material, Voltage, Train Type - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/overhead-catenary-system?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Vital Drivers Catalyzing Growth in the Overhead Catenary System Market" As cities expand and the demand for efficient public transport intensifies, the Overhead Catenary System (OCS) market is experiencing

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top